Skip to main content
. 2020 Oct 21;25:100329. doi: 10.1016/j.jbo.2020.100329

Table 2.

Overview of vitamin D deficiency, insufficiency and sufficiency among patients with malignant bone tumours compared to patients with benign bone tumours.

Patients Malignant Bone Tumours Benign Bone Tumours Overall
Vitamin D sufficient (≥30 ng/ml) 16.9% 27.5% 23.6%
Vitamin D insufficient (20–29 ng/ml) 22.9% 25.3% 24.4%
Vitamin D deficient (<20 ng/ml) 60.2% 47.2% 52%